LeadIQ logo
Learn more at LeadIQ.com
Mirxes

Mirxes Employee Directory

Biotechnology ResearchSingapore, Singapore201-500 Employees

Mirxes is a Singapore-headquartered biotechnology company whose mission is to save lives through early, actionable, and personalized diagnoses across the care continuum.

We are Asia-centered, starting with Southeast Asia, and have global ambitions. We have research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. We have sales and distribution networks worldwide.

Our flagship product is GASTROClear, the world’s first molecular blood test for early detection of gastric cancer, able to detect around 90% of patients with Stage I and II cancers. 

We continue to build a comprehensive cancer portfolio with early detection tests for lung and thyroid cancer (2022), colorectal and breast cancer (2023), liver and ovarian cancer (2024). We are concurrently building a precision oncology portfolio to provide clinical insights for the complete patient journey.

MiRXES was spun off from A*STAR’s Bioprocessing Technology Institute in 2014 to commercialize an industry-leading qPCR-based technology for microRNA detection. Our ID3EAL discovery tool and workflow has been adopted by top academic and industry partners globally and is backed by the world’s first industry standard for microRNA-base diagnostics.

Our versatile platform technology and capabilities have broad applications in the discovery of biomarkers and diagnosis of diseases. We are starting with early cancer detection, but we will also be addressing unmet clinical needs in cardiovascular, metabolic, and infectious diseases.

We responded to COVID-19 by leveraging our capabilities to mass produce and distribute over 5 million units of the Fortitude COVID-19 RT-PCR test. This made-in-Singapore diagnostic test, developed by A*STAR and Tan Tock Seng Hospital, has been deployed in 13 Singapore hospitals and clinical labs and exported to over 45 countries worldwide. Post-COVID, we will leverage this network to commercialize multi-cancer early detection tests.

Find Mirxes employees' phone numbers or email addresses

Mirxes Global Highlights

Location
Employees

Asia
213

Minus sign iconPlus sign icon
  • Singapore
    197
  • Japan
    7
  • China
    4
  • Malaysia
    2
  • Philippines
    2
  • Thailand
    1

North America
14

Minus sign iconPlus sign icon
  • United States Of America
    12
  • Canada
    1
  • Costa Rica
    1

Oceania
2

Minus sign iconPlus sign icon
  • Australia
    2

Mirxes's Leadership

Contact profiles from Mirxes

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Mirxes known for?

Minus sign iconPlus sign icon
Mirxes was founded in 2014 operates in the Biotechnology Research industry. The company's main headquarters is located in 2 Tukang Innovation Grove, JTC MedTech Hub, #09-02 Singapore, 618305 SG. Explore Mirxes's company overview page for more information.

What is Mirxes's most common email format?

Minus sign iconPlus sign icon
Mirxes employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Mirxes email formats with LeadIQ.

How many employees does Mirxes have currently?

Minus sign iconPlus sign icon
Mirxes has approximately 201 employees as of October 2024. These team members are located across 3 continents, including AsiaNorth AmericaOceania.

Who are Mirxes's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2024, Mirxes's key employees include:

  • Chief Executive Officer: Y. W.
  • Chief Investor Relations Officer: M. L.
  • Chief Investment Officer: I. H.
  • Chief Investment Officer: I. H.
  • Chief Of Staff: D. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.